Sirtex
Sirtex's SIR-Spheres(R) Microspheres Showcased Nationally on "The Economic Report" Television Show
Published in Medical Letter on the CDC and FDA, January 17th, 2010
Sirtex, a leading developer of targeted and innovative cancer therapies, will be featured on an upcoming episode of "The Economic Report" as part of the show's Medical Innovations for the 21st Century series titled, Leading Developments in Liver Cancer Technologies. The segment focuses on the challenges of treating metastatic liver tumors and the role of SIR-Spheres microspheres in providing patients with a treatment option. The episode will air nationally on Fox Business Network on Sunday, January 3 at 1:30 p.m. EST. Sirtex manufactures SIR-Spheres microspheres, the only FDA-approved microspheres therapy for colorectal liver metastases.1, 2 Treatments for liver tumors are a priority among...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- American Journal of Pathology
Rapid flu testing - JAMA and Archives Journals
Findings suggest cardiovascular devices often approved by FDA without high-quality studies - University of Pittsburgh Schools of the Health Sciences
Short-term school closures may worsen flu pandemics, Pitt study finds - Adverse Drug Reactions
Data from R.K. Pearson et al provide new insights into adverse drug reactions - Bipolar Disorder
Study findings from University of Illinois broaden understanding of bipolar disorder - Breast Cancer
Research from Mayo Clinic reveals new findings on breast cancer - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
